Tomas Reischig

5PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 19, 2023
Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial.

Petr Drenko, Martin Kacer, Lukas Kielberger

|Dec 03, 2021
Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic.

Tomas Reischig, Martin Kacer, Tomas Vlas

|Sep 19, 2019
BK polyomavirus and valganciclovir: Highly suspected association urgently calling for a new randomized trial.

Tomas Reischig, Martin Kacer, Ondrej Hes

|Jun 21, 2019
Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy.

Tomas Reischig, Martin Kacer, Ondrej Hes

Pageof 1